Construction on the site will begin in the fall and is expected to be finished by 2027. North Chicago is already home to ...

Steve Grzanich has the business news of the day with the Wintrust Business Minute. Abbott Laboratories spinoff AbbVie will ...

The project aims to enhance AbbVie’s chemical synthesis capacity to support next-generation neuroscience, immunology, and ...

"AbbVie expands North Chicago API production with $195m investment" was originally created and published by Pharmaceutical ...

AbbVie will invest $195M to expand API manufacturing at its North Chicago plant, boosting U.S. pharmaceutical innovation, ...

The expansion is part of AbbVie’s larger $10 billion commitment to U.S. investment in the face of Trump’s tariff threats.

AbbVie (ABBV) announced a $195 million investment in its North Chicago manufacturing facility to boost domestic API production, reflecting its long-term commitment to U.S. manufacturing. Over the last ...

The current $195 million investment is part of a commitment to invest more than $10 billion for innovation and manufacturing capacity enhancement.

AbbVie, a global leader in life sciences, announced Tuesday the company’s is investing $195 million to expand its North ...

AbbVie (ABBV) announced a $195M investment in its North Chicago, Illinois manufacturing plant to expand domestic active ...

US pharma major AbbVie yesterday announced a $195 million investment in its North Chicago, Illinois manufacturing plant to ...

The company’s commitment to its North Chicago, Ill. plant is part of a previously announced $10 billion capital investment ...